If you’ve received the mark, you may not buy or sell.
That’s a twist.
In what may become a common theme, at least one business owner’s refusing to serve (as is his right) those who have received ‘speck’ protection.
The interview, linked here, shows he’s wide awake and has done his own research.
Those injected are a threat to the rest of us.
Whether or not we’re in the times of the mark (and whether the speck protection is the mark) is of course, debatable.
However, with even a cursory look around, we can see the great deception and the great falling away.
Personally, I presented years ago to family members, that ‘the church’ has become so corrupt, when the time comes, they’ll be the ones distributing the mark.
Does this link prove the point?
“So then because thou art lukewarm, and neither cold nor hot, I will spue thee out of my mouth.”
There’s literally going to be hell to pay for those complicit in this evil.
In a very small way, this site’s doing its part to separate from the complicit; find and walk the narrow path; get the word out.
Back to biotech: Technical and fundamental:
Obviously, the case against biotech continues to build.
There’s now a site that’s been created to track and document speck related information.
Some of the doctors referenced yesterday (time stamp: 13:32), have started a database cataloguing adverse reactions. Nobody else is doing it. Certainly not big pharma.
As presented yesterday, this may be it for the upside in biotech.
LABD (3X inverse SPBIO) downside thrust energy has eroded significantly.
That’s in addition to the largest hourly upward thrust energy spike for LABD since before June 17th, of last year.
Mentioned yesterday, the format of the updates are being changed.
In a cue taken from Dr. Elder about discussing open trades (i.e. not to), at this point, only closed trades will be discussed in the project.
By presenting specific (time, entry, stop, etc.) details on a market action and/or position, that in itself will affect the outcome.
Any engineers reading this will need no further explanation. For more info reference this link.
We’ll leave it with … there’s an open position in LABD. Detail of that position will be discussed when it’s closed.